Exchange: NASDAQ·Updated 07:30 PM EST

CING News

News
all
press releases
Cingulate Inc. (NASDAQ:CING) Short Interest Up 31.7% in April
Cingulate Inc. (NASDAQ:CING - Get Free Report) was the target of a large increase in short interest during the month of April. As of April 15th, there was short interest totaling 1,420,957 shares, an increase of 31.7% from the March 31st total of 1,078,595 shares. Based on an average daily volume...
MarketBeat
Cingulate Inc. (NASDAQ:CING) Short Interest Up 31.7% in April
Cingulate Inc. (NASDAQ:CING - Get Free Report) was the target of a large increase in short interest during the month of April. As of April 15th, there was short interest totaling 1,420,957 shares, an increase of 31.7% from the March 31st total of 1,078,595 shares. Based on an average daily volume...
MarketBeat
More News
Cingulate Inc. (NASDAQ:CING - Free Report) - Equities research analysts at Ascendiant Capital Markets increased their Q1 2026 earnings estimates for Cingulate in a research report issued to clients...
MarketBeat
Cingulate Inc. (NASDAQ:CING - Get Free Report) was the recipient of a large increase in short interest during the month of March. As of March 31st, there was short interest totaling 1,078,595 shares...
MarketBeat
Ascendiant Capital Markets cut their price objective on Cingulate from $58.00 to $55.00 and set a "buy" rating for the company in a research report on Wednesday...
MarketBeat
Roth Mkm decreased their price objective on Cingulate from $16.00 to $14.00 and set a "buy" rating for the company in a research report on Monday...
MarketBeat
Cingulate slipped in premarket trading as investors weighed its wider quarterly loss against a fresh patent win and new funding to support its ADHD drug launch plans.read more...
Benzinga
Cingulate (NASDAQ:CING - Get Free Report) announced its earnings results on Wednesday. The company reported ($0.84) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.56) by ($0.28...
MarketBeat
Cingulate (NASDAQ:CING) will be releasing its Q4 2025 earnings before the market opens on Thursday, March 26. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2026-3-26-cingulate-inc-stock...
MarketBeat
The FDA has set May 31 as the PDUFA target date to decide on Cingulate’s ADHD drug CTx-1301.
Stocktwits
Cingulate (NASDAQ:CING) Shares Up 6.5% - Here's Why...
MarketBeat

Advertisement|Remove ads.